Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (91-100 of 351) with videos related to

Pageof 36
Sort By:
The Lancet. Oncology|October 5, 2015
PD-L1 expression as a potential predictive biomarkerAlberto Fusi, Lucia Festino, Gerado Botti, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 28, 2002
Effective tumor immunotherapy: start the engine, release the brakes, step on the gas pedal,...and get ready to face autoimmunityIñigo Tirapu, Guillermo Mazzolini, Mercedes Rodriguez-Calvillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Targeting T-Cell Costimulation to the Surface of Tumor CellsIñaki Eguren-Santamaría, Miguel F Sanmamed, Paula Molero-Glez, et al.
Journal of Translational Medicine|May 30, 2012
Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011Ivan Martinez Forero, Hideho Okada, Suzanne L Topalian, et al.
Current Gene Therapy|November 20, 2012
Interleukin-15 in gene therapy of cancerMaria C Ochoa, Guillermo Mazzolini, Sandra Hervas-Stubbs, et al.
Cell Stress|July 17, 2019
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicityMaite Alvarez, Itziar Otano, Luna Minute, et al.
Nature Reviews. Immunology|August 31, 2019
Dendritic cells in cancer immunology and immunotherapyStefanie K Wculek, Francisco J Cueto, Adriana M Mujal, et al.
Journal for Immunotherapy of Cancer|April 10, 2019
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigenStefanie K Wculek, Joaquín Amores-Iniesta, Ruth Conde-Garrosa, et al.
Cancer Research|June 17, 2016
Immunostimulatory Monoclonal Antibodies and Immunomodulation: Harvesting the CropPedro Berraondo, María Carmen Ochoa, María Esperanza Rodriguez-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Direct effects of type I interferons on cells of the immune systemSandra Hervas-Stubbs, Jose Luis Perez-Gracia, Ana Rouzaut, et al.
Pageof 36

Showing results (91-100 of 351) with videos related to

Sort By:
Pageof 36
The Lancet. Oncology|October 5, 2015
PD-L1 expression as a potential predictive biomarkerAlberto Fusi, Lucia Festino, Gerado Botti, et al.
Archivum Immunologiae Et Therapiae Experimentalis|March 28, 2002
Effective tumor immunotherapy: start the engine, release the brakes, step on the gas pedal,...and get ready to face autoimmunityIñigo Tirapu, Guillermo Mazzolini, Mercedes Rodriguez-Calvillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2024
Targeting T-Cell Costimulation to the Surface of Tumor CellsIñaki Eguren-Santamaría, Miguel F Sanmamed, Paula Molero-Glez, et al.
Journal of Translational Medicine|May 30, 2012
Workshop on immunotherapy combinations. Society for Immunotherapy of Cancer annual meeting Bethesda, November 3, 2011Ivan Martinez Forero, Hideho Okada, Suzanne L Topalian, et al.
Current Gene Therapy|November 20, 2012
Interleukin-15 in gene therapy of cancerMaria C Ochoa, Guillermo Mazzolini, Sandra Hervas-Stubbs, et al.
Cell Stress|July 17, 2019
Impact of prophylactic TNF blockade in the dual PD-1 and CTLA-4 immunotherapy efficacy and toxicityMaite Alvarez, Itziar Otano, Luna Minute, et al.
Nature Reviews. Immunology|August 31, 2019
Dendritic cells in cancer immunology and immunotherapyStefanie K Wculek, Francisco J Cueto, Adriana M Mujal, et al.
Journal for Immunotherapy of Cancer|April 10, 2019
Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigenStefanie K Wculek, Joaquín Amores-Iniesta, Ruth Conde-Garrosa, et al.
Cancer Research|June 17, 2016
Immunostimulatory Monoclonal Antibodies and Immunomodulation: Harvesting the CropPedro Berraondo, María Carmen Ochoa, María Esperanza Rodriguez-Ruiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2011
Direct effects of type I interferons on cells of the immune systemSandra Hervas-Stubbs, Jose Luis Perez-Gracia, Ana Rouzaut, et al.
Pageof 36